Salim S. Abdool Karim

1992–2025 年に発表

別表記
Salim S Abdool Karim
174
論文数
31,333
被引用数
97
h 指数
169
i10 指数

被引用数

Salim S. Abdool Karim の年別被引用数1961 年: 被引用 1 件1983 年: 被引用 1 件1993 年: 被引用 2 件1997 年: 被引用 1 件1998 年: 被引用 2 件1999 年: 被引用 3 件2000 年: 被引用 12 件2001 年: 被引用 12 件2002 年: 被引用 24 件2003 年: 被引用 29 件2004 年: 被引用 49 件2005 年: 被引用 54 件2006 年: 被引用 65 件2007 年: 被引用 69 件2008 年: 被引用 90 件2009 年: 被引用 134 件2010 年: 被引用 152 件2011 年: 被引用 285 件2012 年: 被引用 287 件2013 年: 被引用 216 件2014 年: 被引用 232 件2015 年: 被引用 272 件2016 年: 被引用 252 件2017 年: 被引用 232 件2018 年: 被引用 197 件2019 年: 被引用 751 件2020 年: 被引用 634 件2021 年: 被引用 1,000 件2022 年: 被引用 1,686 件2023 年: 被引用 671 件2024 年: 被引用 821 件2025 年: 被引用 312 件2026 年: 被引用 15 件1962〜1982 年は被引用が無いため表示していません1984〜1992 年は被引用が無いため表示していません1994〜1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,456 件、この内訳の 26.8%南アフリカ: 引用元論文 1,150 件、この内訳の 8.9%イギリス: 引用元論文 1,097 件、この内訳の 8.5%中国: 引用元論文 612 件、この内訳の 4.8%カナダ: 引用元論文 464 件、この内訳の 3.6%ドイツ: 引用元論文 376 件、この内訳の 2.9%オーストラリア: 引用元論文 331 件、この内訳の 2.6%スイス: 引用元論文 313 件、この内訳の 2.4%オランダ: 引用元論文 304 件、この内訳の 2.4%インド: 引用元論文 301 件、この内訳の 2.3%フランス: 引用元論文 299 件、この内訳の 2.3%イタリア: 引用元論文 254 件、この内訳の 2%
0%26.8%その他 30.5%

分野

  • Medicine54.2%
  • Immunology and Microbiology27.5%
  • Biochemistry, Genetics and Molecular Biology4.8%
  • Health Professions3.2%
  • Social Sciences3.2%
  • Mathematics1.6%
  • その他5.5%

トピック

  • SARS-CoV-2 and COVID-19 Research9.6%
  • HIV Research and Treatment8%
  • HIV/AIDS Research and Interventions6.2%
  • COVID-19 Clinical Research Studies4.7%
  • HIV/AIDS drug development and treatment3%
  • Immune Cell Function and Interaction2.9%
  • その他65.6%

共著者

全論文

検索で開く
  1. The Lancet Commission on lessons for the future from the COVID-19 pandemic

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guillaume Lafortune, Emma Torres, Lauren Barredo, Juliana G E Bartels, Neena Joshi, Margaret Hellard, Uyen Kim Huynh, Shweta Khandelwal, Jeffrey V. Lazarus, Susan Michie - The Lancet 2022 被引用: 869

  2. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carolyn Williamson, Denis York, COMMIT-KZN Team, Rohen Harrichandparsad, Kobus Herbst, Prakash Jeena, Thandeka Khoza, Henrik N. Kløverpris, Alasdair Leslie, Rajhmun Madansein, Nombulelo Magula, Nithendra Manickchund, Mohlopheni J. Marakalala, Matilda Mazibuko, Mosa Moshabela, Ntombifuthi Mthabela, Kogie Naidoo, Zaza M. Ndhlovu, Thumbi Ndung’u, Nokuthula Ngcobo, Kennedy Nyamande, Vinod Patel, Theresa Smit, Adrie J. C. Steyn, Emily Wong, Anne von Gottberg, Jinal N. Bhiman, Richard Lessells, Mahomed‐Yunus S. Moosa, Miles P. Davenport, Túlio de Oliveira, Penny L. Moore, Alex Sigal - Nature 2021 被引用: 1,196

  3. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

    著者: , - The Lancet 2021 被引用: 1,318

  4. Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 被引用: 97

  5. Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kathryn J. Wood, Martin T. Ferris, Jennifer M. Lund, Mark T. Heise, Nigel Garrett, Kristen R. Canady, Salim S. Abdool Karim, Susan J. Little, Sara Gianella, Davey M. Smith, Scott Letendre, Douglas D. Richman, Francesco Cucca, Hanh Trinh, Sandra Sanchez‐Reilly, Joan M. Hecht, Jose A. Cadena Zuluaga, Antonio Anzueto, Jacqueline A. Pugh, South Texas Veterans Health Care System COVID-19 team, Mohamed I. Abdalla, Sylvia Adams, Yemi Adebayo, Joseph Agnew, Saleem Ali, Gregory M. Anstead, Marichu Balmes, Jennifer M. Barker, Deborah Baruch-Bienen, Velma Bible, Angela Birdwell, Stacy Braddy, Stephen Bradford, H. Briggs, Judith Martín Corral, Jennifer J. Dacus, Patrick Danaher, Scott A. DePaul, Jill Dickerson, Jollynn Doanne, Aamir Ehsan, Samantha Elbel, Miguel Escalante, Corina Escamilla, Valerie Escamilla, Robert Farrar, David Feldman, Debra Flores, Julianne Flynn, Delvina Ford, Joanna D. Foy, Megan Culler Freeman, Samantha Galley, Jessica Medina García, Maritza Garza, S. Douglass Gilman, Melanie Goel, Jennifer M. Gómez, Varun Goyal, Sally Grassmuck, S Grigsby, Joshua A. Hanson, Brande Harris, Audrey Haywood, Cecilia A. Hinojosa, Tony T. Ho, Teri Hopkins, Lynn L. Horvath, Aneela Hussain, Ali Jabur ほか 74 名 - Nature Communications 2023 被引用: 91

  6. SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Host & Microbe 2022 被引用: 241

  7. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yongping Yang, Zhenhai Zhang, NISC Comparative Sequencing, James C. Mullikin, James Μ. Binley, Rogier W. Sanders, Ian A. Wilson, John P. Moore, Andrew C. Ward, George Georgiou, Carolyn Williamson, Salim S. Abdool Karim, Lynn Morris, Peter D. Kwong, Lawrence Shapiro, John R. Mascola - Nature 2014 被引用: 756

  8. Long COVID: a review and proposed visualization of the complexity of long COVID

    著者: , , , , , , , , , - Frontiers in Immunology 2023 被引用: 126

  9. A multinational Delphi consensus to end the COVID-19 public health threat

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sabina Faiz Rashid, Magdalena Rathe, Rocío Sáenz, Sudhvir Singh, Malene Trock-Hempler, Sonia Villapol, Peiling Yap, Agnès Binagwaho, Adeeba Kamarulzaman, Ayman El-Mohandes, The COVID-19 Consensus Statement Panel, Maurício L. Barreto, Carlos del Rı́o, Salim Abdulla, Sarah Addleman, Gulnara Aghayeva, Raymond Agius, Mohammed Ahmed, Mohamed Ramy, Pedro Aíde, Soo Aleman, Jean-Patrick Alfred, Shamim Ali, J. Aliaga, Tammam Aloudat, Saleh A. Alqahtani, Jameela Alsalman, John Amuasi, Anurag Agrawal, Wagida A. Anwar, Tânia Cremonini de Araújo-Jorge, Osvaldo Artaza, Leyla Asadi, Yaw Asante Awuku, Michael G. Baker, Lorena Barberia, Ernesto Báscolo, Paul Belcher, Lizett Bell, Adele Schwartz Benzaken, Emil J. Bergholtz, Nahid Bhadelia, Anant Bhan, Stéphane Bilodeau, Ricardo Bitrán, Philomena M. Bluyssen, A Bosman, Fernando A. Bozza, Melanie M. Brinkmann, Andrew Brown, B. Mellado, Elizabeth A. Bukusi, Chris Bullen, Giorgio Buonanno, Rochelle A. Burgess, Matthew Butler, Pauline Byakika‐Kibwika, Báltica Cabieses, Gunilla Carlsson, Fidelia Cascini, Chishala Chabala, M. Chakroun, Kar Keung Cheng, Agnes Chetty, Dmytro Chumachenko, Gregg Consalves, Andrew Conway Morris, Ahmed Cordie, Tumani Corrah, Brenda Crabtree‐Ramírez ほか 252 名 - Nature 2022 被引用: 238

  10. New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lynn Morris, John R. Mascola - Journal of Virology 2015 被引用: 261

  11. Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emily Wong, Richard Lessells, Túlio de Oliveira, Mahomed‐Yunus S. Moosa, Alex Sigal - Nature Communications 2022 被引用: 187

  12. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women

    著者: , , , , , , , , , , , , , , , - Science 2017 被引用: 416

  13. Vaccine access, equity and justice: COVID-19 vaccines and vaccination

    著者: , , , , , , - BMJ Global Health 2023 被引用: 81

  14. Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Virology 2008 被引用: 624

  15. Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection

    著者: , , , , , , , , , , , , , , , , , , , , , , - PLoS Pathogens 2016 被引用: 200

  16. Genital Inflammation and the Risk of HIV Acquisition in Women

    著者: , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2015 被引用: 431

  17. Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review

    著者: , , , , , , , - Infectious Diseases and Therapy 2023 被引用: 99

  18. Factors, enablers and challenges for COVID-19 vaccine development

    著者: , , , , , , , - BMJ Global Health 2023 被引用: 63

  19. Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection

    著者: , , , , , , , , , , , , , , , - Cell Host & Microbe 2018 被引用: 129

  20. New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications

    著者: , - New England Journal of Medicine 2021 被引用: 756

  21. Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells

    著者: , , , , , , , , , , , , , , , , , , - Mucosal Immunology 2015 被引用: 251

  22. The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4 + T Cell Decline and High Viral Load during Acute Infection

    著者: , , , , , , , , , , , , - Journal of Virology 2011 被引用: 472

  23. Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study

    著者: , , , , , , , , , , , , - Sexually Transmitted Infections 2014 被引用: 210

  24. Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023

    著者: , , , , , , , , , , , , , , - Nature Medicine 2024 被引用: 109